Discovering and Developing Novel,
Oral, Small-Molecule Therapeutics

At Kallyope, we focus on big health challenges that matter to patients and families. We aim to discover and develop effective, easy to use, and well-tolerated oral agents addressing metabolic, neurological, and gastrointestinal diseases.

The Kallyope Story

Inside every human body is a complex, unexplored network of metabolic, neurological, and gastrointestinal interconnections. Our scientists are unlocking the mysteries of this network to develop oral therapies for obesity and diabetes; neurological disorders, including migraine; and gastrointestinal disease, including celiac disease.

Our Science

We are pursuing novel approaches to discovering medicines for metabolic conditions, neurological disorders, and gastrointestinal disease.

Our Technology

Our Klarity™ platform utilizes a broad set of integrated technologies to obtain a more comprehensive understanding of the biology of the gut and signaling pathways between the gut and other organs.

Our Team

Our scientists and accomplished drug developers bring together agile innovation and real-world focus.

Our Culture

Out to do things differently

This is our great adventure: to discover fundamentally new solutions to the world’s most challenging diseases. We are:

  • Courageously Curious
  • Profoundly Connected
  • Made in New York City
Scroll Up

Let’s Work Together

2 researchers working in a lab

Join Our Company

We offer a culture of thinkers AND doers

Partner With Us

Through collaboration, we can go far in advancing human health